Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levamisole for COVID-19 pneumonia
IRCT20131215015805N2Phase 4Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Levamisole with Placebo (2 arms). Primary endpoints: Course of disease, Need for hospitalization and 8 more. Started May 2020; status: completed.
02
Drugs
levamisole
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20131215015805N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131215015805N2.